Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Israel-Hamas war
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    Most Read
    • Israel plans for ‘long war’ and aims to kill top three Hamas leaders
    • US, UK and Australia move to track ‘emerging threats’ in space
    • Israel-Hamas truce talks stall after Mossad negotiators leave Qatar
    • Traders boost US rate cut bets despite pushback from Fed’s Jay Powell
    • US warns that Israel risks ‘strategic defeat’ unless it protects civilians in Gaza
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Companies
      Sections
      • Companies Home
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
      Most Read
      • UN climate talks have focused on renewable energy for too long, Exxon chief says
      • Richard Branson rules out further investment in Virgin Galactic
      • Somerset Capital Management hit by loss of its largest client
      • Signa sold prized KaDeWe property at cut price
      • US moves to choke China’s role in electric vehicle supply chain
    • Tech
    • Markets
      Sections
      • Markets Home
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Wealth Management
      • Trading
      • Moral Money
      • ETF Hub
      Most Read
      • UN climate talks have focused on renewable energy for too long, Exxon chief says
      • Somerset Capital Management hit by loss of its largest client
      • HMRC urges crypto holders to disclose gains
      • Charlie Munger and the Magnificent Seven
      • Wall Street ‘fear gauge’ tumbles as investors spy end of Fed’s inflation fight
    • Climate
    • Opinion
      Sections
      • Opinion Home
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
      Most Read
      • Should we believe Americans when they say the economy is bad?
      • The untimely death of the funeral
      • Charlie Munger and the Magnificent Seven
      • Nvidia played its way to the domination of AI
      • The only way out of the Gaza impasse requires global effort
    • Work & Careers
      Sections
      • Work & Careers Home
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
      • Working It
      Most Read
      • Why companies are tapping the boardroom for their next CEO
      • ‘Double dipping’: why managers worry that staff have a second job on the sly
      • Desks by the hour: why flexible offices are a hit with business
      • The people defending humanity from AI can’t even write a decent press release
      • Should I switch non-profit work for the corporate world?
    • Life & Arts
      Sections
      • Life & Arts Home
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
      Most Read
      • The FT’s 25 most influential women of 2023
      • Celebrity lawyer David Sherborne: ‘I regard myself as on the side of the angels’
      • For women in wine, things are not getting better
      • How to design a home for entertaining
      • Make your own Parthenon marbles
    • HTSI
    MenuSearch
    • Home
    • World
    • US
    • Companies
    • Tech
    • Markets
    • Climate
    • Opinion
    • Work & Careers
    • Life & Arts
    • HTSI
    Financial Times
    SubscribeSign In

    Reckitt Benckiser Group PLC

    Add to myFT Digest

    Add this topic to your myFT Digest for news straight to your inbox

    • Friday, 27 October, 2023
      Investments
      Investors’ Chronicle: Bytes Techonology, Reckitt Benckiser, ScS

      Companies analysis from our sister publication

      Three women relax on an L-shaped sofa
    • Thursday, 31 August, 2023
      US regulator warns Reckitt on baby formula manufacturing standards

      FDA sends letters to UK-listed group and two others after recalls for potential bacterial contamination

      Reckitt’s company logo on a building
    • Wednesday, 23 August, 2023
      Lex
      Reckitt Benckiser: too many sterile quarters leave share price flat Premium content

      Executive team shuffling will hopefully have galvanising effect on FTSE 100 company

      Products produced by Reckitt Benckiser
    • Wednesday, 26 July, 2023
      Reckitt sales volumes fall as customers tighten belts

      Price rises, however, drive revenue growth at maker of Dettol and Nurofen

      Reckitt products
    • Wednesday, 26 April, 2023
      Reckitt picks Kris Licht as new chief

      Former health division head to replace interim boss Nicandro Durante at UK household products group

      A selection of household cleaning brands owned by Reckitt Benckiser
    • Friday, 3 March, 2023
      Investments
      Investors’ Chronicle: Unite Group, Travis Perkins, Reckitt Benckiser

      Companies analysis from our sister publication

    • Wednesday, 1 March, 2023
      Reckitt Benckiser’s sales volumes slide as demand for disinfectant wanes

      Maker of Durex and Nurofen says sales also affected by tough price negotiations with retailers

      Reckitt Benckiser products
    • Tuesday, 3 January, 2023
      Pharmaceuticals sector
      Surge in colds and flu boosts medicine sales

      Demand for over-the-counter remedies rises as rebound in seasonal illnesses combines with Covid-19

      An ill woman in bed with a laptop computer
    • Wednesday, 26 October, 2022
      Households forgo air fresheners and vitamins in cost of living squeeze

      Reckitt Benckiser becomes latest consumer goods group to report falling sales volumes

      Reckitt Benckinser products, Dettol and Cillit Bang
    • Thursday, 1 September, 2022
      Starbucks Corp
      Starbucks names departing Reckitt chief as next CEO

      Laxman Narasimhan to take the reins of coffee chain from interim leader Howard Schultz

      A Starbucks sign on one of its stores in Los Angeles
    • Thursday, 1 September, 2022
      Lex
      Reckitt Benckiser: surprise CEO departure causes market shivers Premium content

      Early exit of Laxman Narasimhan from the consumer goods group will concern shareholders

      Laxman Narasimhan
    • Thursday, 1 September, 2022
      Reckitt Benckiser chief Laxman Narasimhan to step down

      Former head of BAT to take over while consumer group seeks permanent replacement

      Laxman Narasimhan speaking at a summit
    • Wednesday, 27 July, 2022
      Health sector
      Reckitt gains from rising medicine sales as Covid-19 beds in

      Strepsils-maker and rival Haleon benefit from over-the-counter treatments boost from Omicron, colds and flu

      Medicines, including Reckitt’s Strepsils throat lozenges, on shelves at a pharmacy
    • Wednesday, 27 July, 2022
      LexHaleon
      Haleon/Reckitt Benckiser: Covid offers cold cure makers a long-lasting boost Premium content

      Colds and flu are back, and so is demand for remedies

      A woman sneezing into a tissue
    • Thursday, 30 June, 2022
      Lex
      Reckitt Benckiser: infant formula sale is in jeopardy but sales are rising Premium content

      Company’s guidance for 2022 organic sales growth at the upper end of 1-4 per cent may climb

      A selection of Enfa products, a brand of Reckitt Benckiser
    • Thursday, 30 June, 2022
      US retail
      US baby formula crisis spurs debate over lack of competition

      Shortage following Abbott safety scandal draws scrutiny of sector dominated by just two companies

      Low supplies and empty shelves of baby formula at a Walmart in Carmel, Indiana, on May 14 2022
    • Wednesday, 22 June, 2022
      Democrats question Reckitt Benckiser’s plan to sell baby formula unit

      US lawmakers warn a deal with private equity group could ‘shallow out’ market already gripped by critical shortages

      Reckitt Benckiser’s formula products in a store in Manhattan
    • Friday, 29 April, 2022
      Reckitt Benckiser price rises help offset falling demand for disinfectants

      UK consumer products group among several companies that have started passing on commodity cost increases to customers

      Reckitt Benckiser products on display
    • Tuesday, 26 April, 2022
      Reckitt Benckiser seeks up to $10bn for remainder of infant milk business

      Consumer group has written off £8bn after failed takeover

      Enfamil baby formula is displayed at a store in New York City
    • Thursday, 17 February, 2022
      Reckitt vows to protect profit through price rises

      Shares in UK disinfectant maker climb after it reassures investors it can absorb surging cost inflation

      Products produced by Reckitt Benckiser
    • Friday, 24 December, 2021
      Reckitt to sell E45 skincare brand for £200m

      Sale to Swedish group Karo Pharma is part of UK company’s bid to focus on higher-growth areas

      Packets of Strepsils throat lozenges manufactured by Reckitt
    • Tuesday, 26 October, 2021
      Return of colds and flu boosts Reckitt Benckiser

      More social mixing has increased seasonal illnesses and demand for over-the-counter remedies

      Reckitt products: demand for disinfectants such as Dettol soared last year
    • Tuesday, 27 July, 2021
      Reckitt Benckiser shares hit as boom in cleaning products moderates

      Household products group also warns that commodity cost pressures are intensifying

      Bottles of disinfectant including Dettol are seen on a shelf at a shop in London
    • Sunday, 20 June, 2021
      News in-depth
      Reckitt chief signals new era with sale of China baby formula unit

      Laxman Narasimhan is hoping to use pandemic surge in demand to restore competitiveness

    • Saturday, 5 June, 2021
      Personal & Household Goods
      Reckitt Benckiser to sell China baby formula business in $2.2bn deal

      Division has weighed on the consumer goods company’s growth for several years

    Previous page You are on page 1 Next page

    Useful links

    Support

    View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

    Legal & Privacy

    Terms & ConditionsPrivacy PolicyCookie PolicyManage CookiesCopyrightSlavery Statement & Policies

    Services

    Share News Tips SecurelyIndividual SubscriptionsProfessional SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on XFT ChannelsFT Schools

    Tools

    PortfolioToday’s Newspaper (FT Digital Edition)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

    Community & Events

    FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

    More from the FT Group

    Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
    The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
    Financial Times

    International Edition

    Subscribe for full access
    • Switch to UK Edition

    Top sections

    • Home
    • World
      • Israel-Hamas war
      • Global Economy
      • UK
      • US
      • China
      • Africa
      • Asia Pacific
      • Emerging Markets
      • Europe
      • War in Ukraine
      • Americas
      • Middle East & North Africa
    • US
      • US Economy
      • US Companies
      • US Politics & Policy
    • Companies
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
    • Tech
      • Artificial intelligence
      • Semiconductors
      • Cyber Security
      • Social Media
    • Markets
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Wealth Management
      • Trading
      • Moral Money
      • ETF Hub
    • Climate
    • Opinion
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
    • Work & Careers
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
      • Working It
    • Life & Arts
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
    • Personal Finance
      • Property & Mortgages
      • Investments
      • Pensions
      • Tax
      • Banking & Savings
      • Advice & Comment
      • Next Act
    • HTSI
    • Special Reports

    FT recommends

    • Lex
    • Alphaville
    • Lunch with the FT
    • FT Globetrotter
    • #techAsia
    • Moral Money
    • Visual and data journalism
    • Newsletters
    • Video
    • Podcasts
    • News feed
    • FT Live Events
    • FT Forums
    • Board Director Programme
    • myFT
    • Portfolio
    • Today’s Newspaper (FT Digital Edition)
    • Crossword
    • Our Apps
    • Help Centre
    • Subscribe
    • Sign In